| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Interim CFO
2 companies
Romano Sarah is a Chief Financial Officer at KPRX, with reported holdings spanning 2 companies. Recent filings cover 3 purchases and 12 sales. Those positions are worth an estimated $114K at current prices.
Our model assigns Romano Sarah a strong insider score of 81/100, based on 9 past trades. Over a 12-month horizon, 77.8% of those trades were profitable, with an average 12-month return of +45.2%.
Romano Sarah's largest disclosed position is in KPRX as Chief Financial Officer, worth about $60K. Net of sales, the recent Form 4 record there shows accumulation of 72,750 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2018 | KPRX Kiora Pharmaceuticals Inc | Chief Financial Officer | Buy | 62,500 | $0.00 | - | +140.9% | |
| Aug 15, 2017 | KPRX Kiora Pharmaceuticals Inc | Interim CFO | Buy | 10,000 | $1.00 | $10,000.00 | +44.4% | |
| Jun 14, 2017 | KPRX Kiora Pharmaceuticals Inc | Interim CFO | Buy | 20,000 | $0.00 | - | +800.0% |